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A B S T R A C T
Dendritic cells (DCs) are central regulators of tolerance versus immunity. The outcome depends amongst others on DC subset and activation status. Whereas CD11b+ type 2
conventional DCs (cDC2s) initiate proinflammatory helper T (Th)-cell responses, CD103+ cDC1s are crucial for regulatory T-cell (Treg) induction and CD8+ T-cell activation.
DC activation is controlled by the transcription factor NF-κB. Ablation of A20/Tnfaip3, a critical regulator of NF-κB activation, in DCs leads to constitutive DC activation and
development of systemic autoimmunity. We hypothesized that the activation status of cDCs controls the development of autoimmunity.
To target cDCs, DNGR1(Clec9a)-cre-mediated excision of A20/Tnfaip3 was used through generation of Tnfaip3fl/flxClec9a+/cre (Tnfaip3DNGR1−KO) mice. Immune
cell activation was evaluated at 31-weeks of age.
We found that DNGR1-cre-mediated deletion of A20/Tnfaip3 resulted in liver pathology characterized by inflammatory infiltrates adjacent to the portal triads.
Both cDC subsets as well as monocyte-derived DCs (moDCs) in Tnfaip3DNGR1−KO livers harbored an activated phenotype. Specifically, the costimulatory molecule
CD40 in liver cDCs and moDCs was regulated by A20/Tnfaip3 expression. Livers from Tnfaip3DNGR1−KO mice had augmented proportions of Th1, Th17, Treg, and
follicular Th (Tfh)-cells compared to control mice, accompanied by an increase in IgA-producing plasma cells. Serum IgA from Tnfaip3DNGR1−KO mice recognized self-
proteins, specifically cytoplasmic proteins in liver periportal regions.
These data show that enhanced activation of cDCs and moDCs, due to A20/Tnfaip3 ablation, promotes the development of organ-specific autoimmunity but not
systemic autoimmunity. This model could be useful to examine the pathobiological processes contributing to autoimmune liver diseases.
1. Introduction
The adaptive immune response is critically altered in autoimmune dis-
eases, whereby activation of pathogenic T-cells is induced by dendritic cells
(DCs). DCs are known to serve as central regulators in the delicate balance
between tolerance and immunity [1]. During steady state, immature DCs
present self-antigens to T-cells, thereby inducing regulatory CD4+ T-cell
(Tregs), T-cell anergy or autoreactive T-cell deletion [2–4]. These mechan-
isms prevent T-cell mediated autoimmunity [5]. The balance between tol-
erance and immunity depends on the maturation status of DCs, a process
that is strictly regulated [6,7]. During an immune response, DCs are acti-
vated through ligand-receptor interactions that induce activation of the NF-
κB pathway and provoke proinflammatory cytokine production [8]. NF-κB
activation is tightly controlled by several mechanisms. One major inhibitor
of NF-κB signalling is the ubiquitin-editing enzyme TNFα-induced protein 3
(TNFAIP3) or A20 [9]. DC-specific deletion of Tnfaip3/A20 using the Cd11c
promotor in mice (Tnfaip3CD11c−KO mice) resulted in spontaneous activation
of DCs and induction of autoreactive CD4+ T helper (Th)1-cells and Th17-
cells differentiation, causing a severe and complex autoimmune in-
flammatory phenotype [10,11]. Tnfaip3CD11c−KO mice developed features of
inflammatory bowel disease (IBD) [10] and systemic lupus erythematosus
(SLE) [11]. Importantly, genetic polymorphisms in the TNFAIP3 gene are
associated with several human autoimmune disorders [12,13].
DCs comprise different subsets with specialized functions [5]. Both
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conventional DCs (cDCs) and plasmacytoid DCs (pDCs) are present
during steady state. CD103+/CD8+ type 1 cDCs (cDC1s) are important
for peripheral tolerance as they can present tissue-associated self-anti-
gens [5]. During steady state, cDC1s can induce Tregs [14–16], Th-cell
deletion [17], CD8+ T-cell tolerance [17,18], and once activated,
cDC1s also provoke cytotoxic T-cell responses [19]. Strikingly, ablation
of cDC1s does not cause spontaneous autoimmunity [19,20], it only
alters intestinal T-cell homeostasis [21]. Under steady state, CD11b+/
CD4+ type 2 cDCs (cDC2s) also induce T-cell tolerance [22], and pro-
voke Treg proliferation and differentiation [16,23]. Activated cDC2s
strongly promote Th-cell activation and induce Th-cell differentiation
into Th2 [24] or Th17-cells [25]. During inflammation, monocyte-de-
rived DCs (moDCs) arise and produce chemokines to attract immune
cells to the inflammatory lesion [26].
It is unclear what the contribution of different DC subsets is to the
autoimmune phenotype in Tnfaip3CD11c−KO mice. As cDCs are im-
portant instructors of T-cell tolerance, we hypothesized that cDCs cru-
cially contribute to the autoimmune phenotype. To determine cDC
function, we used DNGR1-cre-driven [27] deletion of Tnfaip3/A20
(Tnfaip3DNGR1−KO mice) as DNGR1-cre can induce efficient deletion of
target genes in ∼95% of organ cDC1s, 25–40% of cDC2s, and ∼5–25%
of moDCs [27].
2. Material & methods
2.1. Mice
Male and female mice harbouring a conditional Tnfaip3 allele
flanked by LoxP sites [28] were crossed to mice expressing the Cre
recombinase under the Clec9a promotor (DNGR1) [27], generating
Tnfaip3fl/flxClec9a+/cre mice (Tnfaip3DNGR1−KO mice). Mice were>10
times backcrossed to obtain a C57Bl/6 background. Tnfaip3fl/
flxClec9a+/+ littermates (Tnfaip3DNGR1−WT mice) served as controls. All
mice were sacrificed between 11 and 31 weeks of age.
To trace Tnfaip3-deletion and function in cDCs, we crossed
Tnfaip3+/+xClec9a+/cre mice to Rosa26-Stopfl/fl-YFP mice [29]
(Tnfaip3DNGR1−ROSA-WT mice) and Tnfaip3fl/flxClec9a+/cre mice to
Rosa26-Stopfl/fl-YFP mice (Tnfaip3DNGR1−ROSA-KO mice). Mice were
housed under specific pathogen-free conditions and had ad libitum
access to food and water. All experiments were approved by the animal
ethical committee of the Erasmus MC, Rotterdam, The Netherlands and
comply to the EU Directive 2010/63/EU for animal experiments.
2.2. Cell suspension preparation
Spleen and liver were isolated and used for flow cytometry. Spleens
were homogenized through a 100-μm cell strainer. Erythroid cells
present in the spleen cell suspensions were lysed using osmotic lysis
buffer (8.3% NH4CL, 1% KHCO3, and 0.04% NA2EDTA in Milli-Q).
Liver single-cell suspensions were obtained, as previously described
[30], by digesting with Liberase TM (Roche, Basel, Switzerland) for
30min at 37 °C. After digestion, the livers were homogenized using a
100-μm cell strainer (Fischer Scientific). Hepatocytes were discarded
using two low speed centrifuge steps. Lastly, erythroid cells were lysed
using osmotic lysis buffer.
2.3. Flow cytometry procedures
Flow cytometry surface and intracellular staining procedures have
been described previously [31]. Monoclonal antibodies used for flow
cytometric analyses are listed in Supplementary Table 1. For all ex-
periments, dead cells were excluded using fixable Amcyan viability dye
(eBioscience, San Diego, CA, USA). To measure cytokine production,
cells were stimulated with 10 ng/mL PMA (Sigma-Aldrich, St. Louis, MI,
USA) and 250 ng/mL ionomycin (Sigma-Aldrich) in the presence of
GolgiStop (BD Biosciences, San Jose, CA, USA) for 4 h at 37 °C. Flow
cytometry absolute counting beads (Polysciences, Warrington, PA,
USA) were added to liver flow cytometry samples. Data were acquired
using an LSR II flow cytometer (BD Biosciences) with FACS Diva™
software and analyzed by FlowJo version 9 (Tree Star Inc software,
Ashland, OR, USA).
2.4. Liver histology
The right lobe of the liver was fixated with 4% PFA (Carl Roth,
Karlsruhe, Germany) for 24 h before paraffin embedding. Six-μm-thick
paraffin embedded liver sections were stained with hematoxylin and
eosin, and using Sirius Red (Sigma-Aldrich) and Fast Green (Sigma-
Aldrich) to stain for collagen fibers, as previously described [32]. Liver
pathology was scored using the histopathologic scoring system ac-
cording to Ishak et al. [33] For immunohistochemical stainings, antigen
retrieval on paraffin-sections was established using citrate buffer
(Sigma-Aldrich).
Paraffin sections were stained for Cytokeratin 7, CD3 and B220. The
primary antibodies used for immunohistochemistry are listed in
Supplementary Table 2. Sections were incubated for 1 h with the pri-
mary antibodies. After washing, slides were incubated for 30min with
secondary antibodies (Supplementary Table 2). On paraffin sections
which were stained for Cytokeratin 7 and CD3, the anti-Rabbit ABC
Peroxidase Kit was utilized (Vector Labs, Burlingame, CA, USA). Dia-
minobenzene (DAB) and Fast Blue Alkaline phosphatase substrates
were used to retrieve specific staining.
2.5. Serum measurements
To determine liver function, aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) enzymes were measured in serum.
For total immunoglobulin concentrations, Nunc Microwell plates
(Life technologies, Carlsbad, CA, USA) were coated with 1 μg/ml goat-
anti-mouse IgM, IgA, IgG1, IgG2a, IgG2b, or IgG3 (Southern Biotech,
Birmingham, AL, USA) overnight at 4Co. Wells were blocked with 10%
FCS (Capricorn Scientific, Ebsdorfergrund, Germany) in PBS (Thermo
Scientific, Waltham, MA, USA) for 1 h. Standards and serum were di-
luted in PBS and incubated for 3 h at room temperature. Depending on
the isotype of interest, anti-mouse biotin-labeled IgM, IgA, IgG1, IgG2a,
IgG2b, or IgG3 (Southern Biotech) was incubated for 1 h. Streptavidin-
HRP (eBioscience) and TMB substrate (eBioscience) was used to de-
velop the ELISA and then optical density (OD) was measured at 450 nm
on a Microplate Reader (Bio-Rad, Hercules, CA, USA).
For detection of anti-cardiolipin antibodies, Nunc Microwell plates
were coated with 10 μg/ml cardiolipin from bovine heart (Sigma) in
ethanol and left to dry overnight. For detection of dsDNA, 20 μg/ml
dsDNA from calf thymus (Sigma) was coated overnight on pre-coated
poly-l-lysine microwells. Wells were blocked with 2% BSA/PBS for 2 h,
after which serum was incubated for 2 h. Anti-mouse IgG1 biotin/
streptavidin-HRP (eBioscience) was used to develop the ELISA with
TMB substrate (eBioscience). Detection of immunoglobulin IgG/IgA
versus PDC-E2, sp100 and gp210 was performed as previously de-
scribed [34].
For detection of autoreactive IgA binding to tissues, we used 5 μm
cryo-sectioned liver and pancreas from Rag1KO mouse [35], as these
mice lack mature B-cells and consequently endogenous im-
munoglobulins are absent. After 10min acetone fixation (Sigma) and
10min block with 10% normal goat serum (NGS), sera from
Tnfaip3DNGR1−WT mice (dilution 1/33) and Tnfaip3DNGR1−KO mice (di-
lution 1/100) were incubated for 1 h. Different dilutions were used to
correct for total IgA concentrations in serum from Tnfaip3DNGR1−WT and
Tnfaip3DNGR1−KO mice. Incubation with anti-mouse IgA biotin/strep-
tavidin (BD) and subsequently goat anti-Rat-AP (Sigma), followed by
New Fuchsine (Sigma) staining were used to visualize liver-specific IgA.
Slides were counterstained with Gills hematoxylin (Sigma).
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2.6. Statistics
Statistical significance of data was calculated using the non-para-
metric Mann Whitney U test. P-values< 0.05 were considered sig-
nificant. All analyses were performed using Prism (GraphPad Software
version 9, La Jolla, CA, USA). All data are presented as the mean with
the standard error of the mean (SEM).
3. Results
3.1. Tnfaip3DNGR1−KO mice have spontaneous periportal liver infiltrates
and signs of chronic inflammation
To investigate whether immune homeostasis is altered when cDCs
harbor a DNGR1-mediated deletion of the A20/Tnfaip3 gene, we eval-
uated 31-week-old Tnfaip3DNGR1 mice. Tnfaip3DNGR1−KO mice had
splenomegaly and hyper cellularity in contrast to Tnfaip3DNGR1−WT
littermate controls (Supplementary Fig. 1A). Splenic DC and T-cell
numbers did not differ between Tnfaip3DNGR1−KO mice and
Tnfaip3DNGR1−WT mice (Supplementary Figs. 1B–C). Mainly marginal
zone B-cells contributed to the increase of total splenic B-cells numbers
in Tnfaip3DNGR1−KO mice compared to Tnfaip3DNGR1−WT mice
(Supplementary Fig. 1D).
We next evaluated kidneys, pancreas, intestines, and livers in 31-
week-old Tnfaip3DNGR1−KO mice for signs of inflammation. Spleens of
Tnfaip3DNGR1−KO mice showed mild architectural changes of the white
pulp lymphoid follicles in comparison to WT mice (Supplementary
Fig. 2A). Pancreas, terminal ileum, colon, and kidneys of
Tnfaip3DNGR1−KO mice did not show any sign of inflammation or re-
modelling (Supplementary Figs. 2B–E). In contrast, livers of all
Tnfaip3DNGR1−KO mice showed periportal inflammatory infiltrates at
31-weeks of age compared to WT mice (Fig. 1A/B). Mild interface he-
patitis (also known as piecemeal necrosis) and focal necrosis with in-
flammation, which are often seen in autoimmune hepatitis (AIH) [36],
were observed in Tnfaip3DNGR1−KO mice, but not in WT mice (Fig. 1C/
D). Mild liver fibrosis occurred around portal triads of Tnfaip3DNGR1−KO
mice compared to controls (Fig. 1E/F). These features resulted in a
significantly higher liver histopathologic score for Tnfaip3DNGR1−KO
mice compared to WT mice (Fig. 1G). Also increased cytokeratin 7
expression, a protein expressed in bile ducts and indicative for ductular
reaction, could be observed in Tnfaip3DNGR1−KO mice compared to lit-
termate controls (Fig. 1H). Furthermore, a mild, but significant, in-
crease in serum aspartate aminotransferase (AST) was observed in
Tnfaip3DNGR1−KO mice compared to WT controls (Fig. 1I). No differ-
ences were observed between male or female Tnfaip3DNGR1−KO mice
(data not shown).
Summarizing, these data illustrate that aged Tnfaip3DNGR1−KO mice
develop a spontaneous liver pathology characterized by the presence of
periportal inflammatory infiltrates and signs of chronic inflammation.
3.2. DNGR1-mediated deletion of A20/Tnfaip3 targets both cDCs and
moDCs
In line with histological findings, the total number of liver CD45+
hematopoietic cells was increased in Tnfaip3DNGR1−ROSA-KO mice com-
pared to Tnfaip3DNGR1−ROSA-WT mice (Fig. 2A). Within liver CD45+
cells, we determined the different DC subsets (Fig. 2B). The proportion
of DCs from total CD45+ cells was lower in Tnfaip3DNGR1−ROSA-KO mice
compared to Tnfaip3DNGR1−ROSA-WT mice, but total liver DC numbers
were not significantly different (Fig. 2C). Conventional DC1s and cDC2s
were neither significantly altered as proportions of DCs nor in cell
numbers between the two genotypes (Fig. 2D/E). To investigate
DNGR1-cre mediated deletion efficiency and the effect of A20/Tnfaip3
ablation on liver cDC homeostasis, we examined Tnfaip3DNGR1−ROSA-WT
mice and Tnfaip3DNGR1−ROSA-KO mice, in which YFP expression can be
used as a lineage tracer of DNGR1 expression. Similar to other organs
[27], in livers of Tnfaip3DNGR1−ROSA-WT mice ∼95% of cDC1s showed
YFP expression, which was reduced to ∼55% in Tnfaip3DNGR1−ROSA-KO
mice (Fig. 2F). YFP expression in liver cDC2s did not differ between
Tnfaip3DNGR1−ROSA-WT mice and Tnfaip3DNGR1−ROSA-KO mice and re-
mained ∼35% (Fig. 2F). The absolute number of YFP+ cDC1s was si-
milar between Tnfaip3DNGR1−ROSA-WT mice and Tnfaip3DNGR1−ROSA-KO
mice (Fig. 2G). Plasmacytoid DCs in liver were unaffected by DNGR1-
mediated deletion (∼2% YFP+; data not shown). We next determined
Kupffer cells and monocyte-derived DCs (moDCs) (Fig. 2H). The total
number of both Kupffer cells and moDCs was increased in
Tnfaip3DNGR1−KO mice compared to Tnfaip3DNGR1−WT mice (Fig. 2I).
While Kupffer cell proportions of CD45+ cells were similar, moDCs
significantly expanded as a proportion of CD45+ cells in
Tnfaip3DNGR1−KO mice compared to littermate controls (Fig. 2J). YFP
expression was almost absent in Kupffer cells (< 1%) in both genotypes
(Fig. 2K). Liver moDCs, albeit present in low numbers in
Tnfaip3DNGR1−ROSA-WT mice, harbored a slightly higher YFP expression
WT mice (∼45%) compared to and in Tnfaip3DNGR1−ROSA-WT and
Tnfaip3DNGR1−ROSA-KO mice (∼30%) (Fig. 2K).
Concluding, DNGR1-lineage tracing indicated that in livers of con-
trol mice respectively 95% and 35% of cDC1s and cDC2s, as well as
45% of moDCs express or once expressed DNGR1. Furthermore, due to
deletion of A20/Tnfaip3 55% and 35% of liver cDC1s and cDC2s, along
with 30% of liver moDCs were affected by DNGR1-targeting.
3.3. Surface CD40 expression is increased through both cell-intrinsic and
cell-extrinsic effects of Tnfaip3-deficiency in cDC1s, cDC2s, and moDCs
In livers of Tnfaip3DNGR1−KO mice, both cDC1s and cDC2s showed
significantly enhanced surface expression of the costimulatory molecule
CD40 compared to Tnfaip3DNGR1−WT mice (Fig. 3A/B). In
Tnfaip3DNGR1−WT mice, expression of the co-inhibitory molecule PD-L1
was higher in cDC2s than in cDC1s (Fig. 3B). Both cDC1s and cDC2s in
Tnfaip3DNGR1−KO mice significantly increased PD-L1 expression in
comparison to Tnfaip3DNGR1−WT mice (Fig. 3A/B). No differences were
observed for MHC-I or MHC-II expression in cDCs (data not shown).
We next analyzed whether the altered co-stimulatory molecule ex-
pression was a direct consequence of A20/Tnfaip3-deletion, and com-
pared YFP+ and YFP− cDCs, indicative of A20/Tnfaip3-deficient or
A20/Tnfaip3-sufficient cDCs respectively in Tnfaip3DNGR1−ROSA-KO
mice. YFP+ cDC1s and YFP+ cDC2s from Tnfaip3DNGR1−ROSA-KO mice
harboured significantly higher CD40 expression in comparison to YFP−
cDCs within the same livers (Fig. 3C), whereas PD-L1 expression was
similar in YFP+ and YFP− cDC1s/cDC2s from Tnfaip3DNGR1−ROSA-KO
mice (Fig. 3D). CD40 and PD-L1 expression was already enhanced on
YFP-negative Tnfaip3-sufficient cDC1s/cDC2s from Tnfaip3DNGR1−ROSA-
KO mice compared to Tnfaip3-sufficient cDC1s/cDC2s in
Tnfaip3DNGR1−ROSA-WT mice (Fig. 3C/D). CD40 expression on liver
moDCs did not differ between Tnfaip3DNGR1−KO mice and WT controls
(Fig. 3E/F). In contrast, YFP+ moDCs of Tnfaip3DNGR1−ROSA-KO mice
showed a higher CD40 expression than YFP− moDCs (Fig. 3G/H). Liver
moDCs also harboured higher PD-L1 expression in Tnfaip3DNGR1−KO
mice compared to Tnfaip3DNGR1−WT controls (Fig. 3E/F), but this did
not differ between YFP+ or YFP− moDCs in Tnfaip3DNGR1−ROSA-KO mice
(Fig. 3G/H).
In summary, both liver cDC1s and cDC2s of Tnfaip3DNGR1−KO mice
show an activated phenotype, e.g. increased CD40 and PD-L1 expres-
sion, irrespective of Tnfaip3 deletion. Only CD40 expression is speci-
fically enhanced due to cell-intrinsic loss of Tnfaip3. Liver moDCs of
Tnfaip3DNGR1−KO mice show elevated PD-L1 expression compared to
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Tnfaip3DNGR1−WT mice. Strikingly, enhanced CD40 expression is spe-
cifically observed in Tnfaip3-deficient moDCs.
3.4. Livers of Tnfaip3DNGR1−KO mice have increased proportions of Th1-
cells, Th17-cells and Tregs
The proportion of CD8+ T-cells and natural killer (NK)-cells within
CD45+ cells were elevated in the livers of Tnfaip3DNGR1−KO mice
compared to control mice (Fig. 4A). The percentages of CD4+ Th-cells
and neutrophils were reduced in Tnfaip3DNGR1−KO mice compared to
Tnfaip3DNGR1−WT controls (Fig. 4A). Liver F4/80+ macrophages and
Kupffer cells, monocytes, and B-cell percentages were not significantly
different (Fig. 4A). Due to an increase in absolute numbers of CD45+
hematopoietic cells (Fig. 2A), the total number of CD8+ T-cells, CD4+
Th-cells, and B-cells were significantly increased in Tnfaip3DNGR1−KO
mice compared to controls (Fig. 4B). Clusters of T-cells and B-cells were
observed in the periportal infiltrates of Tnfaip3DNGR1−KO mice, while
only occasionally among hepatocytes in Tnfaip3DNGR1−WT mice
Fig. 1. Tnfaip3DNGR1−KO mice have spontaneous periportal liver infiltrates and signs of chronic inflammation. Tnfaip3DNGR1−WT mice and Tnfaip3DNGR1−KO mice
were analyzed at 31-weeks of age. (A) Hematoxylin and eosin (H&E) stained liver histology with periportal infiltrates (black dashed line) and lobular infiltrates (red
dashed line). (B) Quantification of the portal inflammation score (max. 4). (C) Larger magnification H&E stained liver histology indicating areas of interface hepatitis
(white arrow) and focal necrosis with inflammation (black arrows). (D) Quantified interface hepatitis and focal necrosis with inflammation score (max. 4). (E–F)
Sirius Red staining to stain collagen fibers (E) and enumeration of the resulting fibrosis score (max. 6) (F). (G) Quantification of the total histopathology score (max.
18). (H) Immunohistochemistry of livers for Cytokeratin 7 (brown). (I) Quantification of serum liver enzymes AST and ALT in 31-week-old Tnfaip3DNGR1−WT mice
and Tnfaip3DNGR1−KO mice. Scale bars represent 200 μm. Results of pooled data from 3 experiments and are presented as mean ± SEM of n = 15 mice per group.
*P < 0.05, ***P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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Fig. 2. DNGR1-mediated deletion of A20/
Tnfaip3 targets both cDCs and moDCs.
Tnfaip3DNGR1−ROSA-WT mice and
Tnfaip3DNGR1−ROSA-KO mice were analyzed
at 31-weeks of age. (A) Enumeration of
liver CD45+ cells. (B) Flow cytometric
gating strategy of liver cDC1s (CD103+
CD11b−CD11chiMHC-IIhiFcεRIα-CD64−)
and cDC2s (CD11b+CD103−CD11chiMHC-
IIhiFcεRIα-CD64−). Representative flow
cytometry examples are shown from
Tnfaip3DNGR1−ROSA-WT mice and
Tnfaip3DNGR1−ROSA-KO mice. (C) Total DC
number and proportion of CD45+ cells.
(D–G) Quantification of cDC1s and cDC2s
as a proportion of liver DCs (D), cell num-
bers (E), proportion of YFP+ expressing
cells (F) and the YFP+ cell numbers (G).
(H) Flow cytometric gating strategy
of liver Kupffer cells (F4/
80+CD11bintMHC-IIhiCD64+CD11clo/int)
and moDCs (F4/80+CD11bintMHC-
IIhiCD64+CD11chi) in Tnfaip3DNGR1−WT
mice and Tnfaip3DNGR1−KO mice. (I–K)
Quantification of Kupffer cell and moDC
numbers (I), proportion of CD45+ hema-
topoietic cells (J), and proportion of YFP+
expressing cells (K) using flow cytometry.
Representative data is shown from one ex-
periment of 2 independent experiments.
Results are presented as mean ± SEM of
n = 4–7 mice per group. *P < 0.05,
**P < 0.01.
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Fig. 3. CD40 expression is increased through both cell-intrinsic and cell-extrinsic effects of Tnfaip3-deficiency in cDC1s, cDC2s, and moDCs. Tnfaip3DNGR1−ROSA-WT
mice and Tnfaip3DNGR1−ROSA-KO mice were sacrificed at 31-weeks of age. (A) Histograms showing expression of CD40 and PD-L1 on liver cDC1s and cDC2s. (B)
Quantification of CD40 and PD-L1 by median fluorescence intensity (MFI) on liver cDC1s and cDC2s. (C–D) Quantification of CD40 MFI (C) and PD-L1 MFI (D) in
YFP-positive and YFP-negative liver cDC1s and cDC2s. (E) Histograms showing expression of CD40 and PD-L1 on liver moDCs. (F) Quantification of CD40 and PD-L1
by MFI on liver moDCs. (G) Histograms illustrating expression of CD40 and PD-L1 on liver YFP+ and YFP− moDCs in Tnfaip3DNGR1−ROSA-KO mice. (H) Quantification
of CD40 and PD-L1 by MFI in YFP-positive and YFP-negative liver moDCs in Tnfaip3DNGR1−ROSA-KO mice. Representative data is shown from one experiment of 2
independent experiments. Results are presented as mean ± SEM of n= 4–7 mice per group. Significance in (C,H) is only shown for YFP+ and YFP− cells in
Tnfaip3DNGR1−ROSA-KO mice. *P < 0.05, **P < 0.01.
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(Fig. 4C). In Tnfaip3DNGR1−KO mice, the majority of inflammatory le-
sions in the portal triads consisted of T-cells only (Fig. 4C). In addition,
clusters of DCs and CD8+ T-cells were localised in periportal infiltrates
in Tnfaip3DNGR1−KO mice, compared to sparsely located DCs and CD8+
T-cells in control mice (Supplementary Fig. 3A). DNGR1+ cells, most
likely cDC1s, were also localised within these periportal infiltrates of
Tnfaip3DNGR1−KO mice (Supplementary Fig. 3B).
The percentage of effector CD44+ CD8+ T-cells was increased in
Tnfaip3DNGR1−KO mice compared to WT controls, however the
percentage of granzyme B or interferon gamma (IFNγ)-positive CD8+ T-
cells was unaltered (Supplementary Fig. 4). No differences were ob-
served in the proportions of CD44+ effector liver Th-cells (Fig. 4D), but
the proportions of liver Foxp3+CD25+ Tregs were augmented in
Tnfaip3DNGR1−KO mice in comparison to WT mice (Fig. 4E). Increased
percentages of IFNγ single-positive, IFNγ/IL-10 double-producing, and
IL-17A single-positive Th-cells were found in livers of Tnfaip3DNGR1−KO
mice compared to WT mice (Fig. 4F/G/H). No differences were ob-
served in IL-10 single-positive Th-cells (Fig. 4G). A central cytokine
Fig. 4. Livers of Tnfaip3DNGR1−KO mice have increased proportions of Th1-cells, Th17-cells and Tregs. Tnfaip3DNGR1−WT mice and Tnfaip3DNGR1−KO mice were
sacrificed at 31-weeks of age. (A) Representation of liver immune cell proportions, being F4/80+ cells (CD45+F4/80+CD11bint), CD8+ T-cells (CD3+CD8+), Th-
cells (CD3+CD4+), B-cells (CD19+), monocytes (CD11b+CD11c−GR1−NK1.1-), neutrophils (CD11b+GR1+NK1.1-), total DCs, and NK-cells (NK1.1+, GR1-). (B)
Quantification of CD8+ T-cells, Th-cells and B-cells (CD19+B220+) in liver. (C) Immunohistochemistry of livers for CD3+ (brown, T-cells) and B220+ (purple, B-
cells) cells in 31-week-old Tnfaip3DNGR1−KO mice and Tnfaip3DNGR1−WT mice also indicated by arrowheads. (D–E) Quantification of the proportion activated (CD44+)
Th-cells (D) and Tregs (E) using flow cytometry. (F) A representative example of flow cytometry data of liver CD4+ Th-cells with IFNγ, IL-10 and IL-17A production is
shown for Tnfaip3DNGR1−WT mice and Tnfaip3DNGR1−KO mice. (G–H) Percentages of cytokine-producing Th-cells is shown, being IFNγ single-positive, IFNγ/IL-10
double-positive, IL-10 single-positive (G) and IL-17A single-positive (H) using flow cytometry. Representative data from one experiment is shown out of 4 experi-
ments for (B, D), 2 experiments (G–H) or 1 experiment (A,C). Results are presented as mean ± SEM of n = 4 mice per group. *P < 0.05. (For interpretation of the
references to colour in this figure legend, the reader is referred to the Web version of this article.)
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produced by DCs that provokes differentiation of IFNγ-producing Th-
cells is interleukin-12 (IL-12). Within the periportal infiltrates of livers
in Tnfaip3DNGR1−KO mice, IL-12-positive cells could be observed and not
in control mice (Supplementary Fig. 3C).
In summary, liver CD8+ T-cells, Th-cells, and B-cells in
Tnfaip3DNGR1−KO mice increase in number due to a total increase in
hematopoietic cells and they accumulate in the periportal regions. Th-
cells within livers from Tnfaip3DNGR1−KO mice showed augmented
proportions of IFNγ and IL-17A single-producing Th-cells and IFNγ/IL-
10 double-producing Th-cells.
3.5. Livers of Tnfaip3DNGR1−KO mice contain increased Tfh-cells and
plasma cells, likely producing liver-specific IgA antibodies
The presence of liver inflammatory lesions with both T-cells and B-
cells could indicate direct communication of follicular T-helper (Tfh)-
cells with germinal center (GC) B-cells. In Tnfaip3DNGR1−KO mice, the
proportions and absolute numbers of Tfh-cells (Fig. 5A/B) as well as the
number GC B-cells and plasma cells (Fig. 5C) in the livers were sig-
nificantly increased compared to littermate controls. Moreover, total
IgG1 and IgA concentrations were significantly elevated in the serum of
31-week-old Tnfaip3DNGR1−KO mice compared to WT controls (Fig. 5D).
This increase coincided with significantly increased numbers of IgG1+
and IgA+ plasma cells in spleens and bone marrow (BM) (Fig. 5E/F). In
liver, only IgA+ plasma cells were significantly increased in
Tnfaip3DNGR1−KO mice compared to control mice (Fig. 5G). Re-
markably, we detected increased serum IgG1 and IgA already in 11-
week-old mice (Supplementary Fig. 5A).
We next investigated whether IgG1 and IgA from Tnfaip3DNGR1−KO
mice recognized self-antigens, but could not detect significant differ-
ences for antibodies against pyruvate dehydrogenase complex subunit
E2 (PDC-E2), sp100, glycoprotein 210 (gp210), dsDNA or cardiolipin
(Fig. 5H/I/J). While IgG1 anti-dsDNA and anti-cardiolipin was en-
hanced in Tnfaip3DNGR1−KO mice compared to WT mice, these con-
centrations were very low in comparison to the reference serum of
lupus-prone lpr mice (on average concentration of 100 arbitrary units/
ml) (Fig. 5J) and most likely not physiological relevant as no IgG de-
position nor pathology was observed in the kidneys of Tnfaip3DNGR1−KO
mice (Supplementary Fig. 2D/E).
We next examined whether serum IgG1 or IgA of Tnfaip3DNGR1−KO
mice recognized liver-specific proteins. Serum IgG1 from
Tnfaip3DNGR1−KO mice did not bind proteins present in liver or pancreas
(data not shown). In contrast, serum IgA from 6 out of 10 mice from a
panel of 31-week-old Tnfaip3DNGR1−KO mice recognized antigens in the
liver periportal regions, while this was only detected by serum IgA from
1 out of 9 WT mice (Fig. 5K/L). Primarily liver cytoplasmic proteins
were recognized by serum IgA from Tnfaip3DNGR1−KO mice (Figure 5M).
Importantly, serum IgA from 11-week-old Tnfaip3DNGR1−KO mice did
not recognize liver-specific proteins, whereas total IgA was elevated at
that age (Supplementary Fig. 5A/B), indicating that the auto-reactivity
of IgA developed after the age of 11 weeks. Serum IgA from ∼30% of
Tnfaip3DNGR1−KO mice recognized pancreas-specific proteins, albeit
with reduced staining intensity compared to liver tissue
(Supplementary Fig. 5C/D).
In summary, livers of Tnfaip3DNGR1−KO mice contain increased
number of Tfh-cells, GC B-cells, and IgA+ plasma cells, accompanied by
elevated serum IgG1 and IgA concentrations. Importantly, IgA from
Tnfaip3DNGR1−KO mice recognized self-proteins, specifically cyto-
plasmic proteins of cells within the hepatic periportal regions, which
could be involved in the pathogenesis of liver inflammation.
4. Discussion
DCs play a crucial role in the maintenance of tolerance during
steady state. The activation status of DCs can act like a switch in the
development of tolerance or immunity [6]. Previously we and others
have shown that DC-specific ablation of A20/Tnfaip3 led to sponta-
neous DC activation and subsequently T and B-cell activation, resulting
in an inflammatory phenotype resembling SLE [11] or IBD [10]. DCs
comprise different subsets and cDCs are primarily known to maintain
tolerance [17,22]. To investigate whether A20/Tnfaip3 deletion in
cDCs induces autoimmunity, we crossed Tnfaip3-floxed mice to Clec9a/
DNGR1-cre recombinase mice, as previously this promotor was shown
to mainly target cDCs in wild-type mice [27].
In contrast to A20/Tnfaip3 ablation in all DC subsets, which in-
duced systemic autoimmune disease resembling SLE [11] or IBD [10] in
mice, Tnfaip3DNGR1−KO mice develop organ-specific autoimmune dis-
ease. Aged Tnfaip3DNGR1−KO mice acquired aggravated liver in-
flammatory infiltrates, consisting mainly of T-cells and some B-cells,
adjacent to the portal triads and in lobules. This was accompanied by
increased autoreactive IgA in serum, recognizing liver cytoplasmic
proteins. DNGR1-driven targeting of DCs in the liver of control mice
was similar to other organs [27], being ∼95% in cDC1s, ∼35% in
cDC2s and ∼45% in moDCs. However, in Tnfaip3DNGR1−KO mice we
found a striking decrease in the proportions of targeted cDC1s (∼55%).
It is not very likely that the DNGR1-driven excision in cDC1s was re-
duced in Tnfaip3DNGR1−KO mice. Rather, this finding indicates that due
to A20/Tnfaip3-ablation, DC homeostasis was disturbed. Furthermore,
liver cDC1s, cDC2s and moDCs show an enhanced activation status
(e.g., increased CD40 expression) upon A20/Tnfaip3-ablation.
First signs of chronic liver inflammation, shown by increased cyto-
keratin 7 expression [37] and liver fibrosis, were found in 24-week-old
Tnfaip3DNGR1−KO mice (data not shown) and further increased at 31-
weeks of age. Kidneys and intestines, did not show inflammatory le-
sions, and only very mild inflammation was observed in pancreas. In-
flammation plays an important role in several liver pathologies, and
genome-wide association studies (GWAS) have revealed TNFAIP3 single
nucleotide polymorphisms (SNPs) associated to primary biliary cir-
rhosis (PBC) [38,39] and autoimmune hepatitis (AIH) [40,41]. Our data
show that A20/Tnfaip3-deletion in cDCs and moDCs leads to sponta-
neous (auto) immune responses in the liver.
Strikingly, DNGR1-cre mediated deletion of A20/Tnfaip3 in cDC1s
reduces the proportion of cells targeted by DNGR1 from ∼95% in
Tnfaip3DNGR1−WT mice to ∼55% in Tnfaip3DNGR1−KO mice. This could
be induced by an enhanced sensitivity of cDC1s to undergo apoptosis,
which is also regulated by A20/Tnfaip3 [42]. As the total number of
DNGR1-targeted cDC1s was similar between Tnfaip3DNGR1−WT mice
and Tnfaip3DNGR1−KO mice, this suggests that Tnfaip3-deficient cDC1s
do not undergo apoptosis. The reduced proportion of Tnfaip3-deleted
cDC1s in Tnfaip3DNGR1−KO mice could be a consequence of a robust
Fig. 5. Livers of Tnfaip3DNGR1−KO mice contain increased Tfh-cells and plasma cells, likely producing liver-specific IgA antibodies. Tnfaip3DNGR1−WT mice and
Tnfaip3DNGR1−KO mice were sacrificed at 31-weeks of age. (A) Flow cytometry data of liver Tfh-cells (CD3+CD4+CXCR5+PD1+) from Tnfaip3DNGR1−KO mice and
control mice. (B) Quantification of the proportion Tfh-cells and cell numbers. (C) Enumeration of liver GC B-cells (CD19+B220+CD95+IgD−) and plasma cells
(B220−CD138+). (D) Quantification of all serum immunoglobulin isotypes in 31-week-old mice. (E–G) Enumeration of IgG1+ plasma cells (B220−CD138+IgG1+)
and IgA+ plasma cells (B220−CD138+IgGA+) in spleen (E), bone marrow (F), and liver (G). (H–J) Assessment of autoreactive IgG and IgA immunoglobulins towards
PDC-E2 (H), IgG towards sp100 and gp210 (I) and IgG1 towards dsDNA and cardiolipin (J) in serum from 31-week-old mice using ELISA. 100 arbitrary units
represent the average level of lupus-prone lpr mice in (J). (K) Livers from Rag1KO mice were incubated with serum from 31-week-old Tnfaip3DNGR1−WT and
Tnfaip3DNGR1−KO mice and assessed for IgA binding. (L) Negative and positive autoreactive IgA staining numbers on Rag1KO livers using serum from Tnfaip3DNGR1−KO
mice or Tnfaip3DNGR1−KO mice, depicted in pie-chart format, and in (M) higher magnification of bound IgA on Rag1KO livers. Results are presented as mean ± SEM
of n = 4–19 mice per group. *P < 0.05, **P < 0.01, ****P < 0.0001. Scale bars represent 200 μm.
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selective advantage for the residual Tnfaip3-sufficient cDC1s in the
Tnfaip3DNGR1−KO mice, as total CD45+ hematopoietic cells and thus
total DCs increase in the liver. Alternatively, monocytes can adopt to a
cDC1-phenotype in the presence of inflammatory signals [43] and start
expressing cDC1-typical molecules, like CD103, XCR1, and IRF8. Ad-
ditional studies are needed to identify the cause for the increase in
Tnfaip3-sufficient cDC1s in Tnfaip3DNGR1−KO mice.
Next to DCs, the liver contains other myeloid antigen presenting
cells (APCs) such as Kupffer cells and moDCs. Kupffer cell proportions
in Tnfaip3DNGR1−KO mice remained constant, while moDCs slightly in-
creased in Tnfaip3DNGR1−KO mice livers, most likely recruited due to
liver inflammation [44,45]. Approximately 30% of moDCs in
Tnfaip3DNGR1−KO mice were targeted by DNGR1-driven Cre expression
and consequently deleted Tnfaip3. While kidneys are also known to
have a similar proportion of DNGR1-Cre-mediated deletion [27], we
saw no inflammation in kidneys in Tnfaip3DNGR1−KO mice. Never-
theless, the liver phenotype observed in Tnfaip3DNGR1−KO mice will
most likely not be solely induced by Tnfaip3 ablation in cDCs, because
affected moDCs may also contribute. Liver cDC1s, cDC2s, and moDCs
are activated upon A20/Tnfaip3-ablation, indicated by enhanced co-
stimulatory CD40 expression. Subtle differences in CD40 expression on
cDCs can lead to substantial differences in T-cell activation, possibly
due to a threshold effect. For instance, a 2-fold higher CD40 increase on
cDC1s in non-obese diabetic (NOD) mice turns the balance from tol-
erant Tregs to effector Th1-cell responses [46]. In contrast, absence of
CD40 on APCs/DCs during inflammatory conditions expands the
number of Tregs [47,48]. Thus, enhanced CD40 expression on cDCs and
a proportion of moDCs in Tnfaip3DNGR1−KO could well explain the in-
creased induction of Th1-cells in the liver. Remarkably, transgenic mice
with constitutive CD11c-specific CD40-signalling have a break in tol-
erance, which coincided with increased Th1 and Th17-cell responses
and strikingly also elevated serum IgA [49]. These features are also
observed in Tnfaip3DNGR1−KO mice. Evaluating CD40 expression on
A20/Tnfaip3-deficient and A20/Tnfaip3-sufficient cDCs within the
same Tnfaip3DNGR1−KO mouse demonstrated that CD40 expression is
largely, but not completely regulated by A20/Tnfaip3 in a cell-auton-
omous way. Suppression of CD40 expression by A20/Tnfaip3 has also
been demonstrated in in vitro mesothelial cells [50]. However, elevated
CD40 expression was also observed on A20/Tnfaip3-sufficient cDCs
from Tnfaip3DNGR1−KO mice compared to control mice, suggesting
CD40 expression is additionally influenced by cell-extrinsic factors. In
Tnfaip3DNGR1−KO mice both cDCs and moDCs expressed higher surface
levels of the co-inhibitory molecule PD-L1 which was most likely
regulated cell-extrinsically as both A20/Tnfaip3-deficient and A20/
Tnfaip3-sufficient cDCs within the same Tnfaip3DNGR1−KO mouse har-
bored similar elevated expression compared to control mice. Increased
PD-L1 expression is probably driven by enhanced IFNγ [51], produced
by liver Th1-cells and CD8+ T-cells (data not shown) in
Tnfaip3DNGR1−KO mice.
The inflammatory infiltrates in Tnfaip3DNGR1−KO mouse livers con-
tained CD8+ T-cells, Th-cells, and B-cells. These lymphocytes were
detected next to DCs in the periportal inflammatory infiltrates, which
could imply local T- and B-cell activation. A number of genes involved
in T-cell activation, such as IL12A, IL12RB2 and STAT4, all involved in
IL-12R signalling, are strongly associated to liver autoimmune biliary
diseases [52], and involved in Th1 and Th17-cell polarization.
Tnfaip3DNGR1−KO mice showed increased liver Th1-cells and Th17-cells,
together with augmented IL-12-producing cells, most likely being DCs
or B-cells, which were present around periportal infiltrates.
Although the percentage of IFNγ-producing CD8+ T-cells did not
increase in livers of Tnfaip3DNGR1−KO mice, their total cell number did
(data not shown). While the Th1 cytokine IFNγ is hepatotoxic [53] and
plays pathological roles in mouse models of autoimmune liver disease
[54,55], controversy exists regarding the function of the Th17 cytokine
IL-17A, being either protective [56] or pathogenic [54,57]. In our
study, Th17-cells appeared dispensable for liver inflammation in
Tnfaip3DNGR1−KO mice, as the liver pathology was unaltered in the
absence of liver IL-17A+ Th-cells (data not shown). Since Th-cell
transfer from IFNγ-overexpressing mice induced similar liver pathology
[58] as observed in Tnfaip3DNGR1−KO mice, this could be indicative that
Th1-cells are pathogenic in Tnfaip3DNGR1−KO mice. Strikingly, the ma-
jority of IFNγ-producing Th-cells co-expressed IL-10 in livers from
Tnfaip3DNGR1−KO mice, which has broad anti-inflammatory properties.
Expression of IL-10 by Th1-cells could be a self-regulatory mechanism
to prevent excessive local inflammation [59], as IL-10 can reduce IL-12
secretion from DCs [60].
Aggregation of DCs, T-cells, and B-cells in the livers of
Tnfaip3DNGR1−KO mice could promote active TLO formation, in which a
GC reaction with help of Tfh-cells would support B-cell activation, class
switching, and antibody production. Indeed, liver Tfh-cells, GC B-cells,
and plasma cells are increased in Tnfaip3DNGR1−KO mice. In auto-
immune liver disease patients, liver Tfh-cells are expanded compared to
healthy controls [61] and Tfh-cells even correlate with serum anti-nu-
clear antibody (ANA) titers [62]. Elevated IgG [63] or IgM [64] are
often seen in autoimmune liver diseases, which are known to correlate
with circulating Tfh-cells [65]. The increased liver Tfh-cells in
Tnfaip3DNGR1−KO mice may have contributed to establishing elevated
serum total IgG and IgA from a young age. In autoimmune liver disease,
increased autoreactive IgA is observed [66], which we also find in
Tnfaip3DNGR1−KO mice. Serum of Tnfaip3DNGR1−KO mice contained au-
toreactive IgA specifically recognizing cytoplasmic proteins within the
periportal regions. It is currently unclear why only liver-specific auto-
reactive IgA is observed. This might be related to the observed increase
in total IgA+ plasma cells but not in total IgG1+ plasma cells in the
liver, which points to a specific defect in the control of the IgA response.
As liver periportal inflammation was already present on 11-weeks of
age, but autoreactive IgA was not yet detected in Tnfaip3DNGR1−KO mice
at that time, this could indicate that auto-antibodies do not initiate liver
pathology but rather exacerbate the phenotype.
In summary, DNGR1-cre-mediated deletion of A20/Tnfaip3 in cDCs
and moDCs provokes chronic liver inflammatory infiltrates surrounding
the portal triads. A20/Tnfaip3 directly controls CD40 expression in
liver cDC1s, cDC2s and moDCs in vivo, with increased proportions of
Th1-cells, Th17-cells, and Tfh-cells and autoreactive B-cell activation.
Our data illustrate that activation of conventional DCs and moDCs is
sufficient to shift the balance between tolerance and immunity and
induces organ-specific autoimmunity, especially in the liver.
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